Integrum AB (publ) (STO: INTEG.B)
Sweden
· Delayed Price · Currency is SEK
26.00
-0.40 (-1.52%)
Oct 3, 2024, 5:29 PM CET
Integrum AB Revenue
Integrum AB had revenue of 19.79M SEK in the quarter ending July 31, 2024, a decrease of -4.56%. This brings the company's revenue in the last twelve months to 109.51M, up 36.81% year-over-year. In the fiscal year ending April 30, 2024, Integrum AB had annual revenue of 110.46M with 42.44% growth.
Revenue (ttm)
109.51M
Revenue Growth
+36.81%
P/S Ratio
4.55
Revenue / Employee
3.04M
Employees
39
Market Cap
517.90M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 110.46M | 32.91M | 42.44% |
Apr 30, 2023 | 77.55M | 16.72M | 27.50% |
Apr 30, 2022 | 60.82M | 17.02M | 38.87% |
Apr 30, 2021 | 43.80M | 16.19M | 58.62% |
Apr 30, 2020 | 27.61M | 1.84M | 7.16% |
Apr 30, 2019 | Pro | Pro | Pro |
Apr 30, 2018 | Pro | Pro | Pro |
Apr 30, 2017 | Pro | Pro | Pro |
Apr 30, 2016 | Pro | Pro | Pro |
Apr 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.17B |
Camurus AB (publ) | 1.59B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |